Ruggiero A, Wright J, Ferguson S, Lewis M, Emerson K, Iwamoto H
ACS Chem Neurosci. 2012; 3(10):767-81.
PMID: 23077721
PMC: 3474274.
DOI: 10.1021/cn3000718.
Obregon A, Schetinger M, Correa M, Morsch V, Silva J, Martins M
Neurochem Res. 2005; 30(3):379-84.
PMID: 16018582
DOI: 10.1007/s11064-005-2612-5.
Overstreet D, RUSSELL R
Psychopharmacology (Berl). 1982; 78(2):150-5.
PMID: 6817373
DOI: 10.1007/BF00432254.
Baratti C, Introini I, Huygens P, Gusovsky F
Psychopharmacology (Berl). 1983; 80(2):161-5.
PMID: 6136061
DOI: 10.1007/BF00427961.
Large T, Rauh J, de Mello F, Klein W
Proc Natl Acad Sci U S A. 1985; 82(24):8785-9.
PMID: 3866251
PMC: 391522.
DOI: 10.1073/pnas.82.24.8785.
Modulation of memory by post-training epinephrine: involvement of cholinergic mechanisms.
McGaugh J
Psychopharmacology (Berl). 1988; 94(3):379-85.
PMID: 3128815
DOI: 10.1007/BF00174693.
Behavioral and physiological effects associated with changes in muscarinic receptors following administration of an irreversible cholinergic agonist (BM 123).
RUSSELL R, Smith C, Booth R, JENDEN D, Waite J
Psychopharmacology (Berl). 1986; 90(3):308-15.
PMID: 3097716
DOI: 10.1007/BF00179182.
Relation between behaviorally augmented tolerance and upregulation of muscarinic receptors in the CNS: effects of chronic administration of chronic administration of scopolamine.
RUSSELL R, Ehlert F, Hwa J
Psychopharmacology (Berl). 1986; 88(1):33-9.
PMID: 3080776
DOI: 10.1007/BF00310509.
Behavioral and physiological effects of an aziridinium analog of oxotremorine (BM130).
RUSSELL R, Crocker A, Booth R, JENDEN D
Psychopharmacology (Berl). 1986; 88(1):24-32.
PMID: 3080775
DOI: 10.1007/BF00310508.
Cholinergic modulation of memory in rats.
Haroutunian V, Barnes E, Davis K
Psychopharmacology (Berl). 1985; 87(3):266-71.
PMID: 3001803
DOI: 10.1007/BF00432705.
Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats.
Yamazaki N, Kato K, Kurihara E, Nagaoka A
Psychopharmacology (Berl). 1991; 103(2):215-22.
PMID: 2027921
DOI: 10.1007/BF02244206.
